SG11201406548WA - Anti-malarial agents - Google Patents
Anti-malarial agentsInfo
- Publication number
- SG11201406548WA SG11201406548WA SG11201406548WA SG11201406548WA SG11201406548WA SG 11201406548W A SG11201406548W A SG 11201406548WA SG 11201406548W A SG11201406548W A SG 11201406548WA SG 11201406548W A SG11201406548W A SG 11201406548WA SG 11201406548W A SG11201406548W A SG 11201406548WA
- Authority
- SG
- Singapore
- Prior art keywords
- dundee
- international
- ddi
- nethergate
- university
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
- C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1206280.8A GB201206280D0 (en) | 2012-04-10 | 2012-04-10 | Anti-malarial agents |
| PCT/GB2013/050633 WO2013153357A1 (en) | 2012-04-10 | 2013-03-14 | Anti-malarial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201406548WA true SG11201406548WA (en) | 2015-01-29 |
Family
ID=46177063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201406548WA SG11201406548WA (en) | 2012-04-10 | 2013-03-14 | Anti-malarial agents |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9115088B2 (zh) |
| EP (1) | EP2836483B1 (zh) |
| JP (1) | JP6088639B2 (zh) |
| CN (1) | CN104302624B (zh) |
| BR (1) | BR112014025416B1 (zh) |
| CA (1) | CA2870140C (zh) |
| ES (1) | ES2587683T3 (zh) |
| GB (1) | GB201206280D0 (zh) |
| HU (1) | HUE030572T2 (zh) |
| IN (1) | IN2014DN09314A (zh) |
| MY (1) | MY166153A (zh) |
| PH (1) | PH12014502285B1 (zh) |
| PT (1) | PT2836483T (zh) |
| SG (1) | SG11201406548WA (zh) |
| WO (1) | WO2013153357A1 (zh) |
| ZA (1) | ZA201408094B (zh) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201610724D0 (en) * | 2016-06-20 | 2016-08-03 | Univ Dundee | Anti-infective agents |
| CN108101842B (zh) * | 2017-12-29 | 2021-04-30 | 山东诚汇双达药业有限公司 | 一种2-羟基-4-羧基喹啉的制备方法 |
| EP3773549A1 (en) | 2018-04-11 | 2021-02-17 | Merck Patent GmbH | Combination of quinoline-4-carboxamides and benzonaphthyridine derivatives as antimalarial drug combination |
| CN111084774B (zh) * | 2019-11-29 | 2021-06-15 | 中国科学院广州生物医药与健康研究院 | 吡咯烷类化合物组合物在制备抗疟疾药物中的应用 |
| WO2021149692A1 (en) * | 2020-01-21 | 2021-07-29 | Eisai R&D Management Co., Ltd. | Novel antimalarial agent containing heterocyclic compound |
| EP3892332A1 (en) * | 2020-04-09 | 2021-10-13 | University Of Kentucky Research Foundation | New anti-malarial agents |
| WO2024089045A1 (en) * | 2022-10-24 | 2024-05-02 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | Tasl mimicking molecules and applications thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2502264A (en) | 1946-06-25 | 1950-03-28 | Us Sec War | Quinoline derivatives having antimalarial properties |
| JPH0873355A (ja) * | 1994-09-02 | 1996-03-19 | Mitsui Toatsu Chem Inc | 抗マラリア薬耐性克服剤 |
| TR199800854T2 (xx) * | 1995-11-16 | 1998-08-21 | F.Hoffmann-La Roche Ag | Antis�tma kinolin t�revleri. |
| JP2002505689A (ja) * | 1997-06-19 | 2002-02-19 | セプレイコー インコーポレイテッド | キノリン−インドール抗菌剤、それらに関する用途及び組成物 |
| EP1940814B1 (en) * | 2005-10-21 | 2013-05-22 | Actelion Pharmaceuticals Ltd. | Piperazine derivatives as antimalarial agents |
-
2012
- 2012-04-10 GB GBGB1206280.8A patent/GB201206280D0/en not_active Ceased
-
2013
- 2013-03-14 SG SG11201406548WA patent/SG11201406548WA/en unknown
- 2013-03-14 CA CA2870140A patent/CA2870140C/en active Active
- 2013-03-14 ES ES13711110.0T patent/ES2587683T3/es active Active
- 2013-03-14 EP EP13711110.0A patent/EP2836483B1/en active Active
- 2013-03-14 IN IN9314DEN2014 patent/IN2014DN09314A/en unknown
- 2013-03-14 BR BR112014025416A patent/BR112014025416B1/pt active IP Right Grant
- 2013-03-14 JP JP2015505014A patent/JP6088639B2/ja active Active
- 2013-03-14 MY MYPI2014002888A patent/MY166153A/en unknown
- 2013-03-14 PT PT137111100T patent/PT2836483T/pt unknown
- 2013-03-14 WO PCT/GB2013/050633 patent/WO2013153357A1/en active Application Filing
- 2013-03-14 US US14/391,394 patent/US9115088B2/en active Active
- 2013-03-14 HU HUE13711110A patent/HUE030572T2/en unknown
- 2013-03-14 CN CN201380025617.2A patent/CN104302624B/zh active Active
-
2014
- 2014-10-10 PH PH12014502285A patent/PH12014502285B1/en unknown
- 2014-11-05 ZA ZA2014/08094A patent/ZA201408094B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MY166153A (en) | 2018-06-06 |
| HUE030572T2 (en) | 2017-05-29 |
| CA2870140C (en) | 2018-06-26 |
| EP2836483A1 (en) | 2015-02-18 |
| ZA201408094B (en) | 2017-08-30 |
| GB201206280D0 (en) | 2012-05-23 |
| PH12014502285A1 (en) | 2014-12-15 |
| JP2015512930A (ja) | 2015-04-30 |
| BR112014025416B1 (pt) | 2020-04-22 |
| US9115088B2 (en) | 2015-08-25 |
| PH12014502285B1 (en) | 2014-12-15 |
| CN104302624A (zh) | 2015-01-21 |
| PT2836483T (pt) | 2016-08-26 |
| US20150045354A1 (en) | 2015-02-12 |
| IN2014DN09314A (zh) | 2015-07-10 |
| EP2836483B1 (en) | 2016-07-27 |
| BR112014025416A8 (pt) | 2018-06-12 |
| WO2013153357A1 (en) | 2013-10-17 |
| CA2870140A1 (en) | 2013-10-17 |
| ES2587683T3 (es) | 2016-10-26 |
| BR112014025416A2 (pt) | 2013-10-17 |
| JP6088639B2 (ja) | 2017-03-01 |
| CN104302624B (zh) | 2016-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201406548WA (en) | Anti-malarial agents | |
| SG11201804170RA (en) | Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders | |
| SG11201810983PA (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
| SG11201900947RA (en) | Tlr7/8 antagonists and uses thereof | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201803686UA (en) | Prodrugs of a jak inhibitor compound for treatment of gastrointestinal inflammatory disease | |
| SG11201804934PA (en) | Novel Compounds | |
| SG11201810171SA (en) | Kras g12c inhibitors | |
| SG11201900135YA (en) | N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors | |
| SG11201807301SA (en) | Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (dub) inhibitors | |
| SG11201808990QA (en) | Compositions for topical application of compounds | |
| SG11201805300QA (en) | Heterocyclic compounds as immunomodulators | |
| SG11201408821SA (en) | Selective pi3k delta inhibitors | |
| SG11201810423XA (en) | Pd-1 / pd-l1 inhibitors for cancer treatment | |
| SG11201805645QA (en) | Lsd1 inhibitors | |
| SG11201407682TA (en) | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators | |
| SG11201805044WA (en) | Compounds useful as kinase inhibitors | |
| SG11201805570WA (en) | Systems and methods for long term transdermal administration | |
| SG11201804901WA (en) | Compounds for the treatment of cancer and inflammatory disease | |
| SG11201408238WA (en) | Substituted tricyclic compounds as fgfr inhibitors | |
| SG11201407580YA (en) | Composition comprising two antibodies engineered to have reduced and increased effector function | |
| SG11201407228PA (en) | N-aryltriazole compounds as lpar antagonists | |
| SG11201909083UA (en) | Piperidines as covalent menin inhibitors | |
| SG11201408750VA (en) | NOVEL FUSED PYRIDINE DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS | |
| SG11201407326XA (en) | Compositions and methods for treatment of mucositis |